551-560 of 665 results
Allens partner to chair energy efficiency review
Allens Partner and Head of Innovation Anna Collyer will lead the Australian Government's review into the legislation that regulates the energy efficiency of appliances and equipment. Ms Collyer wil ...
Allens Hub for Technology, Law & Innovation launches research streams
Allens and UNSW have officially launched the Allens Hub for Technology, Law & Innovation, unveiling 10 new research streams to tackle legal issues surrounding data, artificial intelligence, privacy ...
Allens acts for PZ Cussons in successfully defending the first contested 'hub and spoke' cartel case brought by the ACCC
In 2013, the ACCC first took action against: PZ Cussons and Colgate-Palmolive, alleging they had entered into a cartel in relation to the supply of laundry detergents with a third laundry detergent ...
Allens Hub for Technology, Law & Innovation launches to confront the future of law
Allens has joined forces with UNSW to tackle the increasingly complex challenges presented by digital transformation to the legal system with the launch of the Allens Hub for Technology, Law & ...
Allens advises Clearskincare on $127.4m acquisition
Allens has advised the founders of Clearskincare on the sale of the brand's clinic and products businesses to Australian Pharmaceutical Industries (API) for $127.4 million. Under the deal, API will ...
Big data: Allens advises M2 Group on proposed $3 billion merger
Allens has advised M2 Group Ltd on its proposed $3 billion merger with Vocus Communications. Under the proposed merger, announced today, M2 Group shareholders will receive 1.625 Vocus shares for ea ...
Dixon Hospitality says cheers to Beer DeLuxe
Allens has advised Dixon Hospitality on its acquisition of the Beer DeLuxe venues in NSW and Victoria. Dixon has acquired six venues including those in the entertainment precincts of King Street ...
Allens advises Healthscope on sale of Australian pathology business
Allens has acted for one of Australia's leading private healthcare operators, Healthscope Limited, on the sale of its Australian pathology operations to Crescent Capital Partners for $105 million. ...
Don't sweat it - Federal Court finds 'clinical strength' claims on deodorant were not misleading
The Federal Court found in a dispute between Unilver and Beiersdorf, that the use of 'clinical strength' marketing in relation to Nivea deodorants was not false, misleading or deceptive as Unilever had claimed. ...
Measuring ‘spilt milk’
Can food and beverage industry participants be found to have engaged in misleading or deceptive conduct for failure to comply with aspects of relevant regulatory regimes? The Federal Court has confirmed that they can. ...